Richard A. Larson to Drug Discovery
This is a "connection" page, showing publications Richard A. Larson has written about Drug Discovery.
Connection Strength
0.056
-
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Adv. 2018 02 27; 2(4):444-453.
Score: 0.035
-
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm. Blood. 2010 Oct 07; 116(14):2420-8.
Score: 0.021